Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Filgrastim vs Filgrastim in Cancer Patients
NCT01285219Phase 3Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2006
- Primary completion
- May 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of pegfilgrastim in neutropenia, sponsored by Chinese Academy of Medical Sciences. Started Jan 2006; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01285219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285219.